Silva C.
109
Coauthors
10
Documentos
Volumen de publicaciones por año
Cargando gráfico
| Año de publicación | Num. Publicaciones |
|---|---|
| 2007 | 3 |
| 2011 | 1 |
| 2012 | 2 |
| 2014 | 1 |
| 2017 | 3 |
Publicaciones por áreas de conocimiento
Cargando gráfico
| Área de conocimiento | Num. Publicaciones |
|---|---|
| Medicina interna | 4 |
| Inflamación | 2 |
| Enfermedad cardiovascular | 2 |
| Infección | 1 |
| Patología | 1 |
| Fisiología | 1 |
| Nutrición | 1 |
| Biología molecular | 1 |
| Bioquímica | 1 |
| Biología celular | 1 |
Publicaciones por áreas temáticas
Cargando gráfico
| Área temática | Num. Publicaciones |
|---|---|
| Enfermedades | 7 |
| Farmacología y terapéutica | 6 |
| Medicina y salud | 4 |
| Fisiología humana | 2 |
| Medicina forense; incidencia de enfermedades | 1 |
| Economía | 1 |
| Bioquímica | 1 |
| Salud y seguridad personal | 1 |
| Historia de América del Norte | 1 |
Principales fuentes de datos
| Origen | Num. Publicaciones |
|---|---|
| Scopus | 10 |
| Google Scholar | 2 |
| RRAAE | 0 |
Cargando gráfico
Coautores destacados por número de publicaciones
| Coautor | Num. Publicaciones |
|---|---|
| Valmore Bermúdez | 10 |
| Arráiz N. | 5 |
| Toledo A.C. | 4 |
| Torres Y. | 4 |
| Rojas-Quintero J. | 4 |
| Añez-Ramos R. | 4 |
| Amell A. | 4 |
| Salazar-Vílchez J. | 3 |
| Bermúdez F.A. | 3 |
| Leal E.M. | 3 |
Cargando gráfico
Top Keywords
Cargando gráfico
Publicaciones del autor
Tumor necrosis factor as an inflammatory marker in patients with chronic obstructive pulmonary disease
ArticleAbstract: COPD is a chronic inflammatory disease that mainly affects bronchi less than 2 mm in diameter. ThisPalabras claves:Chronic obstructive pulmonary disease, Cigarette, inflammation, inflammatory mediators, Tumor necrosis factorAutores:Bello L.M., Silva C., Valmore BermúdezFuentes:scopusIncrease of malondialdehido and nitric oxide in COPD patients
ArticleAbstract: Introduction: Chronic Obstructive Pulmonary Disease (COPD) is an entity characterized by the persistPalabras claves:Chronic obstructive pulmonary disease, Malondialdehyde, Nitric oxide, Oxidative profileAutores:Bello L.M., Linares S., Silva C., Valmore BermúdezFuentes:scopusFront-line medicines used in the treatment of tuberculosis
ArticleAbstract: Tuberculosis has emerged as an enormous global public health epidemic. Worldwide, it is the second lPalabras claves:Estreptomicin, Ethambutol, isoniazid, M. Tuberculosis, Pyrazinamide, rifampinAutores:Arráiz N., Bermúdez F.A., Leal E.M., Rodriguez M., Silva C., Valdelamar L., Valmore BermúdezFuentes:scopusC-reactive protein: Clinical and epidemiological perspectives
ReviewAbstract: An important etiopathogenic component of cardiovascular disease is atherosclerosis, with inflammatioPalabras claves:Autores:Añez-Ramos R., Apruzzese V., Chávez-Castillo M., Martínez M.S., Rojas-Quintero J., Salazar-Vílchez J., Silva C., Toledo A.C., Torres Y., Valmore BermúdezFuentes:scopusPharmacologic treatment of obesity: Present, past and future
ReviewAbstract: Obesity is a chronic, stigmatized and costly disease that is rarely curable and is increasing in prePalabras claves:body mass index, Energetic balance, Noradrenegic agents, obesity, Orlistat, Serotoninergic agents, SibutraminAutores:Amell A., Bermúdez F.A., Cabrera M., Leal E.M., Mengual-Moreno E., Rodriguez M., Silva C., Toledo A., Valdelamar L., Valmore BermúdezFuentes:scopus